Blood cancers

Transformed lymphomas have excellent outcomes with rituximab

Patients with transformed lymphomas treated with rituximab have excellent survival outcomes without autologous stem cell transplantation consolidation (ASCT), Victorian clinicians say. A retrospective study of 45 lymphoma patients with histological transformation treated at the Department of Clinical Haematology, Monash Health, between 2002 and 2017 found that they had a five-year overall survival (OS) of 69% ...

Already a member?

Login to keep reading.

© 2020 the limbic